Clinical Trial Update: TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209) [Phase 4]

View source ↗

Summary

Pfizer completed a Phase 4 follow-up study evaluating the persistence of TBE antibody and the need for booster vaccination in children and adolescents (Follow-u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• Tick-Borne Encephalitis Antibody (Pfizer) (neutralizing monoclonal antibody against Tick-Borne Encephalitis virus)

Snippet

Sponsor: Pfizer | Conditions: Encephalitis, Tick-Borne | Phase 4 | Status: COMPLETED